Clinical Trial Update: Effectiveness and Safety in Administrating CNU® Capsule to Refractory Functional Dyspepsia Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating the effectiveness and safety of CNU® Capsule in refractory functional dyspepsia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• CNU® Capsule

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Dyspepsia, Biliary Dysplasia | Phase 1, Phase 2 | Status: COMPLETED